Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Anderson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Research|March 13, 2002
Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft modelsHelen Brady, Sonal Desai, Leah M Gayo-Fung, et al.
Cytokine|August 7, 2003
SP500263, a novel SERM, blocks osteoclastogenesis in a human bone cell model: role of IL-6 and GM-CSFMay S Kung Sutherland, Stephanie G Lipps, Nandita Patnaik, et al.
Molecular Pharmacology|February 21, 2002
Differential response of estrogen receptors alpha and beta to SP500263, a novel potent selective estrogen receptor modulatorHelen Brady, Mary Doubleday, Leah M Gayo-Fung, et al.
Experimental Neurology|August 24, 2006
Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primatesTomás R Guilarte, Ming-Kai Chen, Jennifer L McGlothan, et al.
Molecular Therapy. Methods & Clinical Development|November 11, 2024
An <i>in vitro</i> and <i>in vivo</i> efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPsVidyullatha Vasireddy, Casey A Maguire, David W Anderson, et al.
Advanced Functional Materials|February 3, 2025
N-Dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL-1β Productions for Antitumor ImmunityAshley R Hoover, Kaili Liu, Coline Furrer, et al.
Oncogene|August 7, 2003
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancerJennifer L Clancy, Michelle J Henderson, Amanda J Russell, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Research|March 13, 2002
Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft modelsHelen Brady, Sonal Desai, Leah M Gayo-Fung, et al.
Cytokine|August 7, 2003
SP500263, a novel SERM, blocks osteoclastogenesis in a human bone cell model: role of IL-6 and GM-CSFMay S Kung Sutherland, Stephanie G Lipps, Nandita Patnaik, et al.
Molecular Pharmacology|February 21, 2002
Differential response of estrogen receptors alpha and beta to SP500263, a novel potent selective estrogen receptor modulatorHelen Brady, Mary Doubleday, Leah M Gayo-Fung, et al.
Experimental Neurology|August 24, 2006
Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primatesTomás R Guilarte, Ming-Kai Chen, Jennifer L McGlothan, et al.
Molecular Therapy. Methods & Clinical Development|November 11, 2024
An <i>in vitro</i> and <i>in vivo</i> efficacy evaluation of gene therapy candidate SBT101 in mouse models of adrenomyeloneuropathy and in NHPsVidyullatha Vasireddy, Casey A Maguire, David W Anderson, et al.
Advanced Functional Materials|February 3, 2025
N-Dihydrogalactochitosan Drives Conventional and Alternative Activations of STING to Synergize Type I IFN and IL-1β Productions for Antitumor ImmunityAshley R Hoover, Kaili Liu, Coline Furrer, et al.
Oncogene|August 7, 2003
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancerJennifer L Clancy, Michelle J Henderson, Amanda J Russell, et al.
Pageof 4